Hatchtech's Series A - II Round

Hatchtech raised a round of funding on December 12, 2012.

Hatchtech is the developer of a proprietary next generation head lice treatment, DeOvo™. DeOvo™, recently renamed as Xeglyze™ Lotion, is a head lice product in development that has been studied …

Articles about Hatchtech's Series A - II Round: